These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36102924)
1. A case of topical imiquimod induced fatigue. Raman J; Bisbee E; Missall TA; Saikaly SK J Dermatolog Treat; 2022 Dec; 33(8):3202-3204. PubMed ID: 36102924 [TBL] [Abstract][Full Text] [Related]
2. The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature. Scarfì F; Patrizi A; Veronesi G; Lambertini M; Tartari F; Mussi M; Melotti B; Dika E Dermatol Ther; 2020 Nov; 33(6):e14165. PubMed ID: 32772481 [TBL] [Abstract][Full Text] [Related]
3. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. Cannon PS; O'Donnell B; Huilgol SC; Selva D Br J Ophthalmol; 2011 Dec; 95(12):1682-5. PubMed ID: 20702431 [TBL] [Abstract][Full Text] [Related]
4. Clearance of invasive melanoma with topical imiquimod. Moon SD; Spencer JM J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337 [TBL] [Abstract][Full Text] [Related]
5. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin. Miller AK; Dusing R; Meggison A; Aires D J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648 [TBL] [Abstract][Full Text] [Related]
6. [Topical treatment of melanoma skin metastases with imiquimod]. Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347 [TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Love WE; Bernhard JD; Bordeaux JS Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854 [TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous tumors with topical 5% imiquimod cream. Alessi SS; Sanches JA; Oliveira WR; Messina MC; Pimentel ER; Festa Neto C Clinics (Sao Paulo); 2009; 64(10):961-6. PubMed ID: 19841702 [TBL] [Abstract][Full Text] [Related]
9. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature. Ellis LZ; Cohen JL; High W; Stewart L Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583 [TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Wagstaff AJ; Perry CM Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284 [TBL] [Abstract][Full Text] [Related]
12. Imiquimod-Associated Localized Skin Ulceration in a Patient With Uncontrolled Diabetes. McKinzie AH; Christman MA Obstet Gynecol; 2022 Aug; 140(2):316-319. PubMed ID: 35852284 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Hesling C; D'Incan M; Mansard S; Franck F; Corbin-Duval A; Chèvenet C; Déchelotte P; Madelmont JC; Veyre A; Souteyrand P; Bignon YJ Br J Dermatol; 2004 Apr; 150(4):761-7. PubMed ID: 15099376 [TBL] [Abstract][Full Text] [Related]
14. Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. Florin V; Desmedt E; Vercambre-Darras S; Mortier L Invest New Drugs; 2012 Aug; 30(4):1641-5. PubMed ID: 21748297 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma. Burke B; Bailie JE Biomed Pharmacother; 2022 Apr; 148():112710. PubMed ID: 35217280 [TBL] [Abstract][Full Text] [Related]
16. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. Powell AM; Robson AM; Russell-Jones R; Barlow RJ Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462 [TBL] [Abstract][Full Text] [Related]
17. Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ. Ward C; DePalo DK; Patel N; Carr M; Longbottom B; Cunningham K; Culbreth A; Reed R; Harkins A; Puleo C; Correa L; Seminario-Vidal L; Zager JS J Drugs Dermatol; 2023 May; 22(5):457-464. PubMed ID: 37133478 [TBL] [Abstract][Full Text] [Related]
18. Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases. Mauldin IS; Wages NA; Stowman AM; Wang E; Olson WC; Deacon DH; Smith KT; Galeassi N; Teague JE; Smolkin ME; Chianese-Bullock KA; Clark RA; Petroni GR; Marincola FM; Mullins DW; Slingluff CL Cancer Immunol Immunother; 2016 Oct; 65(10):1201-12. PubMed ID: 27522582 [TBL] [Abstract][Full Text] [Related]
19. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma. Sriprakash K; Godbolt A Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986 [TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream. Schroeder TL; Sengelmann RD J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]